TX SB426 | 2023-2024 | 88th Legislature
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Engrossed on April 5 2023 - 50% progression, died in committee
Action: 2023-04-17 - Referred to Public Health
Pending: House Public Health Committee
Text: Latest bill text (Engrossed) [HTML]
Status: Engrossed on April 5 2023 - 50% progression, died in committee
Action: 2023-04-17 - Referred to Public Health
Pending: House Public Health Committee
Text: Latest bill text (Engrossed) [HTML]
Summary
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Title
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Sponsors
| Sen. Angela Paxton [R] | Sen. Bob Hall [R] |
Roll Calls
2023-04-05 - Senate - Read 3rd time (Y: 0 N: 1 NV: 0 Abs: 0) [FAIL]
2023-04-05 - Senate - Three day rule suspended (Y: 0 N: 1 NV: 0 Abs: 0) [FAIL]
2023-04-05 - Senate - Three day rule suspended (Y: 0 N: 1 NV: 0 Abs: 0) [FAIL]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-04-17 | House | Referred to Public Health |
| 2023-04-17 | House | Read first time |
| 2023-04-06 | House | Received from the Senate |
| 2023-04-05 | Senate | Reported engrossed |
| 2023-04-05 | Senate | Record vote |
| 2023-04-05 | Senate | Passed |
| 2023-04-05 | Senate | Read 3rd time |
| 2023-04-05 | Senate | Record vote |
| 2023-04-05 | Senate | Three day rule suspended |
| 2023-04-05 | Senate | Vote recorded in Journal |
| 2023-04-05 | Senate | Passed to engrossment as amended |
| 2023-04-05 | Senate | Vote recorded in Journal |
| 2023-04-05 | Senate | Amended |
| 2023-04-05 | Senate | Amendment(s) offered FA1 Paxton |
| 2023-04-05 | Senate | Read 2nd time |
| 2023-04-05 | Senate | Vote recorded in Journal |
| 2023-04-05 | Senate | Rules suspended-Regular order of business |
| 2023-04-04 | Senate | Placed on intent calendar |
| 2023-03-31 | Senate | Committee report printed and distributed |
| 2023-03-31 | Senate | Reported favorably w/o amendments |
| 2023-03-29 | Senate | Vote taken in committee |
| 2023-03-29 | Senate | Considered in public hearing |
| 2023-03-27 | Senate | Co-author authorized |
| 2023-03-22 | Senate | Left pending in committee |
| 2023-03-22 | Senate | Testimony taken in committee |
| 2023-03-22 | Senate | Considered in public hearing |
| 2023-03-22 | Senate | Scheduled for public hearing on . . . |
| 2023-02-15 | Senate | Referred to Health & Human Services |
| 2023-02-15 | Senate | Read first time |
| 2023-01-12 | Senate | Filed |
| 2023-01-12 | Senate | Received by the Secretary of the Senate |
Subjects
COVID-19
Health
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
MEDICAL BOARD, TEXAS
MEDICINE & PRESCRIPTION DRUGS
RIGHT TO TREAT ACT
Health
Health Care Providers
Health--General
Health--Other Diseases & Medical Conditions
MEDICAL BOARD, TEXAS
MEDICINE & PRESCRIPTION DRUGS
RIGHT TO TREAT ACT
